GlassScriptPhysician profile
Susan S Murrey
NPI 1902908056
$2,082.74
in general payments reported to CMS, 2019-2025
37 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $189 · 2021: $96.62 · 2022: $354 · 2023: $302 · 2024: $290 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $288.06 | 2019-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Therapeuticsmd, INC. | $173.42 | 2019-2022 | |
| Abbvie INC. | $173.15 | 2019-2023 | |
| Pfizer INC. | $144.00 | 2019-2023 | |
| Astellas Pharma US INC | $116.26 | 2019-2025 | Veozah |
| Allergan, INC. | $106.67 | 2019-2020 | |
| Exact Sciences Corporation | $78.76 | 2023-2025 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $78.38 | 2021-2024 | Ova1 |
| Avion Pharmaceuticals | $70.96 | 2019-2023 | Balcoltra |
| Coopersurgical, INC. | $70.59 | 2019-2025 | Paragard T 380a |
| Biogen, INC. | $66.61 | 2024-2025 | Zurzuvae |
| Amgen INC. | $62.24 | 2019-2023 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $50.75 | 2019-2020 | |
| Agile Therapeutics, INC. | $48.74 | 2022-2023 | Twirla |
| Mayne Pharma Commercial LLC | $46.67 | 2022-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $43.35 | 2023 | Surgiflo Hemostatic Matrix, Mega Soft |
| Novo Nordisk INC | $40.91 | 2022-2025 | Wegovy |
| Amag Pharmaceuticals, INC. | $35.43 | 2019 | |
| Millicent US INC | $34.87 | 2025 | Intrarosa, Femlyv |
| Exeltis, USA INC. | $34.81 | 2022-2024 | Slynd |
| Dysis Medical, INC. | $30.98 | 2020 | |
| Channel Medsystems, INC. | $28.70 | 2025 | |
| Sanofi Pasteur INC. | $26.26 | 2024 | |
| Minerva Surgical, INC | $25.20 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $24.67 | 2019-2020 | |
| Organon LLC | $21.26 | 2022 | |
| Convatec INC. | $20.58 | 2023 | |
| Tactile Systems Technology INC | $19.79 | 2019 | |
| Medtronic Vascular, INC. | $15.62 | 2019 | |
| Scynexis, INC. | $14.90 | 2022 | |
| Lilly USA, LLC | $14.50 | 2025 | Zepbound |
| Covidien LP | $13.92 | 2020 | |
| Medline Industries LP | $13.13 | 2022 | |
| Mission Pharmacal Company | $12.96 | 2019 | |
| Duchesnay USA Incorporated | $12.19 | 2019 | |
| Roche Diagnostics Corporation | $11.84 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Murrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.